Table 2.
Association between expression of BPTF, vimentin and E-cadherin and clinicopathological characteristics in CRC patients (n = 105)
| Variables | BPTF (n) | Vimentin (n) | E-cadherin (n) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| High | Low | P value | High | Low | P value | High | Low | P value | |
| Age (years) | |||||||||
| ≤60 | 43 | 21 | 37 | 27 | 14 | 50 | |||
| >60 | 28 | 13 | 0.9060 | 22 | 19 | 0.6756 | 13 | 28 | 0.2608 |
| Gender | |||||||||
| Male | 42 | 23 | 36 | 29 | 16 | 49 | |||
| Female | 29 | 11 | 0.4018 | 23 | 17 | 0.8320 | 11 | 29 | 0.7426 |
| Tumor size (cm) | |||||||||
| ≤5 | 38 | 24 | 40 | 22 | 21 | 41 | |||
| >5 | 33 | 10 | 0.0961 | 19 | 24 | 0.0390 | 6 | 37 | 0.0217 |
| Histology grade | |||||||||
| Low (G1–G2) | 42 | 28 | 34 | 36 | 24 | 46 | |||
| High (G3–G4) | 29 | 6 | 0.0183 | 25 | 10 | 0.0261 | 3 | 32 | 0.0092 |
| UICC stage | |||||||||
| I/II | 32 | 29 | 32 | 29 | 23 | 38 | |||
| III/IV | 39 | 5 | 0.0001 | 27 | 17 | 0.3642 | 4 | 40 | 0.0020 |
| Nodal metastasis | |||||||||
| Negative | 36 | 25 | 28 | 33 | 15 | 46 | |||
| Positive | 35 | 9 | 0.0265 | 31 | 13 | 0.0124 | 12 | 32 | 0.7563 |
| Recurrence | |||||||||
| Negative | 40 | 28 | 38 | 30 | 22 | 46 | |||
| Positive | 31 | 6 | 0.0090 | 21 | 16 | 0.9313 | 5 | 32 | 0.0349 |
UICC Union for International Cancer Control
Significant results (P < 0.05) are given in bold